ICPT — Intercept Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Intercept Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	C2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-Q	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	436	653	470	420	486
Net Total Accounts Receivable
Net Total Receivables	25.7	38	41.5	28.3	26.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets	482	721	546	508	540
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10.4	18.4	18.7	6.84	6.11
Other Long Term Assets
Total Assets	509	755	580	527	554
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	114	162	179	168	230
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	490	703	747	711	461
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	19.1	51.6	-167	-184	93.1
Total Liabilities & Shareholders' Equity	509	755	580	527	554
Total Common Shares Outstanding